Egesta Lopci

52PUBLICATIONS
104CO-AUTHORS
Haematological tumoursAdolescent healthMedical biotechnology diagnostics (incl. biosensors)Oncology and carcinogenesis not elsewhere classifiedMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (52)

|Jul 28, 2026
Molecular, Biochemical, and Bioimaging Markers of MEN Syndromes.

|Jun 03, 2026
​EuroNet-PHL-LP1: Complete resection or low-dose chemo for pediatric low-risk nodular lymphocyte-predominant Hodgkin lymphoma.

|Mar 14, 2026
Cost Analysis of PSMA-PET in the PROSPET-BX Trial.

Egesta Lopci, Cesare Saitta, Alberto Saita

|Mar 13, 2026
Letter to the Editor: "Less is better" does not suit all cases in colon cancer imaging.

Anna Margherita Maffione, Egesta Lopci

|Mar 12, 2026
Immunoprofiling, sex- and age-related determinants of treatment response in paediatric, adolescent and young adult Hodgkin lymphoma.

Valli De Re, Egesta Lopci, Giulia Brisotto

|Mar 09, 2026
Malignant Pleural Mesothelioma (MPM) Evaluation with [11C]-Methionine PET/CT Before and After Talc Pleurodesis.

Egesta Lopci, Angelo Castello, Alberto Testori

Pageof 9

Frequent Collaborators

5 joint publications

Laurent Dercle

5 joint publications

Massimo Castellani

4 joint publications

Samy Ammari

4 joint publications

Maurizio Mascarin